Both the ability of the FCV LC protein to permeate the cellular plasma membrane and to induce apoptosis also occurred in murine and human ovarian cancer cell lines overexpressing survivin, highlighting its potential role in oncological research and as a therapeutic tool. This evidence concerns the gene BIRC5 and ovarian carcinoma.